Sunil Reddy
Academic Appointments
- Clinical Instructor, Medicine - Oncology
Key Documents
Contact Information
-
Clinical Offices
Stanford Cancer Center 875 Blake Wilbur CC 2232 MC 5826 Stanford, CA 94305 Tel Work (650) 736-1234 Fax (650) 736-1373
- Academic Offices
Personal Information Email Tel (650) 736-1234Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cutaneous (Dermatologic) Oncology
- lymphoma/melanoma/cutaneouslymphoma
- Medical Oncology
Professional Education
| Fellowship: | Stanford University School of Medicine CA (2000) |
| Board Certification: | Medical Oncology, American Board of Internal Medicine (2003) |
| Residency: | University of Michigan MI (1997) |
| Internship: | University of Michigan Hospital MI (1995) |
| Medical Education: | UCI College of Medicine CA (1994) |
Scientific Focus
Clinical Trials
- Not Recruiting Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
- Recruiting A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
- Not Recruiting A Study for Patients With Relapsed Cutaneous T-Cell Lymphoma
- Recruiting Pilot Study of Brentuximab Vedotin (SGN-35) in Patients With MF With Variable CD30 Expression Level
- Not Recruiting Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
Publications
- A phase II study of SGN-30 in cutaneous anaplastic large cell lymphoma and related lymphoproliferative disorders. Clin Cancer Res. 2009; (19): 6217-24
- Prognostic factors in primary cutaneous anaplastic large cell lymphoma: characterization of clinical subset with worse outcome. Arch Dermatol. 2009; (6): 667-74
- Indolent primary cutaneous B-cell lymphoma: experience using systemic rituximab. J Am Acad Dermatol. 2008; (6): 953-7
- Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: safety and immunogenicity in a phase I clinical study. Proc Natl Acad Sci U S A. 2008; (29): 10131-6
- Molecular rescue of tumour-specific T cell receptor idiotype from T cell lymphomas. Br J Haematol. 2004; (5): 626-8
- CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma. J Am Acad Dermatol. 2003; (6): 1049-58
Help
Trial Administration